Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

CSL Limited (ASX:CSL)

Pharmaceuticals, Biotechnology & Life Sciences

share price: (EoD)

earnings per share:

dividends per share:

CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.

CSL Limited (ASX:CSL) share price

CSL Limited (ASX:CSL) share price news

ASX Bank Shares
James Dunn

China, rates front and centre

The benchmark S&P/ASX 200 (INDEXASX: XJO) index fell 21.7 points, or 0.3 per cent, to 7393.1, with five of the 11 sub-sectors retreating. The broader All Ordinaries (INDEXASX: XAO) shed 24.6 points, also 0.3 per cent, to 7,622.

ASX Bank Shares
James Dunn

Uranium gives the S&P/ASX 200 (INDEXASX:XJO) a glow

Weaker iron ore prices saw BHP Group Ltd (ASX: BHP) shed 53 cents, or 1.1 per cent, to $47.18, while Rio Tinto Ltd (ASX: RIO) lost 83 cents, or 0.6 per cent, to $128.32, and Fortescue Ltd (ASX: FMG) eased 13 cents, or 0.5 per cent, to $27.24.

Today's ASX news
Rask ASX News Team

RMD and CSL Limited: 2 ASX shares to dig into

The Resmed CDI (ASX:RMD) share price has decreased 12.7% since the start of the 2024. It’s probably worth asking, ‘is the RMD share price good value?’

Skip to content